Edmedcare Introduces Elite Medication for Erectile Dysfunction and a Fast Discreet Online Doctor Consultation
NEW YORK, March 4, 2020 /PRNewswire/ -- Edmedcare.com is offering free, fast, online and discreet consultation for erectile dysfunction with a licensed MD from the privacy of the consumer's home. Once approved, a licensed pharmacy will deliver specially formulated ED medication containing NZT-V and NZT-C to the customer's doorstep.
"Edmedcare has compounded a unique formula that successfully addresses erectile dysfunction by taking Sildenafil 100mg (generic for Viagra) and Tadalafil 20mg (generic for Cialis) and tweaking them with our unique amino blend called NZT-V 112mg and NZT-C 24mg," says Michael Luchen, CEO of Edmedcare. "This treatment is the strongest available ED prescription medication on the market today."
NZT-V contains 112mg of active Sildenafil and 24mg of active Tadalafil. Also available as a Prescription is Generic Viagra "Sildenafil" 100mg and Generic Cialis "Tadalafil" 20mg based on past health history.
The ED medication addresses problems related to Erectile Dysfunction also known as "ED". Edmedcare's online system is HIPAA compliant and starts with a free, online consultation.
About ED Medication:
The ED medication is exclusively available at Edmedcare. NZT-V is an ED Treatment that is compounded by one of our licensed pharmacies which contains 112 mg of Active Generic Viagra "Sildenafil" that's 12 mg higher than any treatment pill available in the market today. The NZT-C contains 24mg Generic Cialis "Tadalafil" which is 4 mg more potent than other tablets. Its pharmacy also adds amino acids like B12 complex to enhance the Viagra and Cialis.
888-9GetMed
Related Images
edmedcare-leader-in-erectile.jpg
Edmedcare - Leader in Erectile Dysfunction
Edmedcare offers a free and fast online consultation with a state- licensed prescriber for ED treatment.
Related Links
Leadership in Erectile Dysfunction Treatments
SOURCE EDmedcare
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article